NZ HIV Medicine Research Review Issue 42

In this issue:

Pricing of branded TAF/emtricitabine vs. generic TDF-emtricitabine for PrEP
Kidney function/tubular health changes with TDF/emtricitabine PrEP
Rapid PrEP uptake after price reduction in Germany
Changing smoking habits in HIV-infected patients
Maintaining HIV care during the COVID-19 pandemic
Virus clearance and antibody response in COVID-19 case with HIV/HCV co-infection
Fostemsavir for multidrug-resistant HIV-1 infection
Long-acting cabotegravir/rilpivirine after oral induction in HIV-1 infection
Long-acting cabotegravir/rilpivirine for maintaining HIV-1 suppression
Weight gain greatest after starting dolutegravir-based ART

Please login below to download this issue (PDF)

Subscribe